4.6 Article

Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis

Journal

FRONTIERS IN ONCOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.609882

Keywords

diffuse large B-cell lymphoma; urinary tract; SEER; prognosis; primary

Categories

Funding

  1. 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZY2016104]
  2. National Natural Science Fund of China [81771569]

Ask authors/readers for more resources

This study utilized the SEER database to investigate the clinical characteristics and prognostic factors of UT-DLBCL patients, revealing that surgical resection and chemotherapy significantly improve survival rates, while factors such as age over 75, male gender, lack of surgical resection or chemotherapy, and stage IV DLBCL may lead to poorer outcomes.
Objective Diffuse large B-cell lymphoma (DLBCL) is the most common histopathological type of non-Hodgkin's lymphoma, which may arise from various extranodal sites. Little is known about the clinical characteristics and survival outcomes of primary DLBCL of the urinary tract (UT). Thus, we conducted this study to explore the independent prognostic factors of patients with UT-DLBCL using the Surveillance, Epidemiology, and End Results (SEER) database. Materials and Methods We searched the Surveillance, Epidemiology, and End Results (SEER) database for the data of patients diagnosed with UT-DLBCL between 1975 and 2016. Data, including demographic tumour stage and therapeutic strategies, such as surgical resection, radiation therapy, and chemotherapy, were collected. The impact of these factors on survival outcomes, including overall survival (OS) and disease-specific survival (DSS), was analysed using Kaplan-Meier curves. Results Four-hundred and eighty-nine patients who met the inclusion criteria were enrolled in the data analysis. The median age was 69 years old. Most cases of UT-DLBCL (72.39%) originated from the kidney, followed by the urinary bladder (24.95%). Both surgical resection and chemotherapy can significantly improve OS and DSS. Patients older than 75 years had the worst survival outcomes. Stage IV DLBCL may be a poor prognostic factor. onclusion To the best of our knowledge, this is the largest population-based study of UT-DLBCL. Advanced age, male gender, lack of surgical resection or chemotherapy, and stage IV DLBCL were poor prognostic factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available